TriSalus Life Sciences (TLSI) EPS (Basic) (2022 - 2026)
TriSalus Life Sciences' (TLSI) quarterly EPS (Basic) came in at $0.03 in Q1 2026, up 107.68% year-on-year from $0.01 in Q1 2025, and up 111.6% quarter-over-quarter from -$0.26 in Q4 2025.
TriSalus Life Sciences (TLSI) EPS (Basic) (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' EPS (Basic) history runs 5 years deep, the most recent figure standing at $0.03 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 107.68% year-over-year to $0.03 in Q1 2026; TTM through Mar 2026 was -$1.13, a 6.8% decrease from a year earlier, with the FY2025 full-year figure at -$1.84, down 40.17% from the prior year.
- EPS (Basic) rose to $0.03 in Q1 2026 per TLSI's latest filing, from -$0.26 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.03 in Q1 2026 and bottomed at -$81.95 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.43 (2024), against an average of -$10.1.
- Across the five-year window, EPS (Basic) tumbled 693.37% in 2025 and soared 107.68% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$81.95 in 2022, then surged by 95.27% to -$3.88 in 2023, then soared by 88.91% to -$0.43 in 2024, then surged by 40.14% to -$0.26 in 2025, then jumped by 111.6% to $0.03 in 2026.
- Per Business Quant, the three latest TLSI EPS (Basic) figures stand at $0.03 (Q1 2026), -$0.26 (Q4 2025), and -$0.96 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.96 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.39 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.21 |
| Mar 31, 2024 | -0.60 |
| Dec 31, 2023 | -3.88 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -35.84 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -81.95 |
| Sep 30, 2022 | -25.95 |